News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,738 Results
Type
Article (15389)
Company Profile (300)
Press Release (272042)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (81362)
Career Advice (233)
Deals (13713)
Drug Delivery (40)
Drug Development (51078)
Employer Resources (33)
FDA (5915)
Job Trends (5292)
News (147569)
Policy (10451)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (987)
Accelerated approval (19)
Adcomms (14)
Allergies (82)
Alliances (22273)
ALS (125)
Alzheimer's disease (1062)
Antibody-drug conjugate (ADC) (241)
Approvals (6102)
Artificial intelligence (285)
Autoimmune disease (110)
Automation (10)
Bankruptcy (109)
Best Places to Work (4664)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (231)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (350)
Cancer (3193)
Cardiovascular disease (240)
Career advice (207)
Career pathing (9)
CAR-T (220)
CDC (6)
Cell therapy (569)
Cervical cancer (15)
Clinical research (43944)
Collaboration (1170)
Company closure (2)
Compensation (594)
Complete response letters (40)
COVID-19 (1144)
CRISPR (86)
C-suite (555)
Cystic fibrosis (112)
Data (4384)
Denatured (15)
Depression (93)
Diabetes (257)
Diagnostics (1556)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (192)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (32271)
Editorial (26)
Employer branding (5)
Employer resources (31)
Events (52424)
Executive appointments (622)
FDA (7697)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (991)
Gene editing (182)
Generative AI (27)
Gene therapy (486)
GLP-1 (517)
Government (1268)
Grass and pollen (3)
Guidances (172)
Healthcare (6865)
HIV (18)
Huntington's disease (44)
IgA nephropathy (74)
Immunology and inflammation (191)
Immuno-oncology (39)
Indications (67)
Infectious disease (1253)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (40)
Intellectual property (168)
Interviews (30)
IPO (7517)
IRA (12)
Job creations (887)
Job search strategy (170)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (245)
Leadership (13)
Legal (1464)
Liver cancer (42)
Longevity (11)
Lung cancer (436)
Lymphoma (255)
Machine learning (26)
Management (7)
Manufacturing (380)
MASH (132)
Medical device (2836)
Medtech (2846)
Mergers & acquisitions (6839)
Metabolic disorders (733)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (232)
Neuropsychiatric disorders (71)
Neuroscience (1991)
Neurotech (1)
NextGen: Class of 2026 (2099)
Non-profit (938)
Now hiring (30)
Obesity (333)
Opinion (140)
Ovarian cancer (131)
Pain (103)
Pancreatic cancer (163)
Parkinson's disease (234)
Partnered (13)
Patents (305)
Patient recruitment (329)
Peanut (44)
People (26988)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15544)
Phase 2 (20426)
Phase 3 (12921)
Pipeline (3290)
Policy (96)
Postmarket research (873)
Preclinical (6566)
Press Release (30)
Prostate cancer (149)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (656)
Real estate (1483)
Recruiting (12)
Regulatory (10142)
Reports (19)
Research institute (1007)
Resumes & cover letters (34)
Rett syndrome (25)
RNA editing (21)
RSV (17)
Schizophrenia (124)
Series A (183)
Series B (135)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (17)
Startups (2032)
State (1)
Stomach cancer (5)
Supply chain (33)
Tariffs (19)
The Weekly (62)
Vaccines (350)
Venture capital (70)
Weight loss (177)
Women's health (25)
Worklife (4)
Date
Last 7 days (352)
Last 30 days (1236)
Last 365 days (18119)
2026 (1689)
2025 (18408)
2024 (20906)
2023 (22801)
2022 (27289)
2021 (28412)
2020 (24006)
2019 (16835)
2018 (12188)
2017 (14069)
2016 (12171)
2015 (14702)
2014 (10594)
2013 (7646)
2012 (7685)
2011 (7793)
2010 (7547)
Location
Africa (174)
Alabama (65)
Alaska (2)
Arizona (72)
Arkansas (5)
Asia (18449)
Australia (3165)
California (7165)
Canada (1861)
China (776)
Colorado (248)
Connecticut (254)
Delaware (235)
Europe (40348)
Florida (909)
Georgia (210)
Hawaii (2)
Idaho (17)
Illinois (427)
India (35)
Indiana (168)
Iowa (8)
Japan (227)
Kansas (83)
Kentucky (9)
Louisiana (7)
Maine (12)
Maryland (751)
Massachusetts (5646)
Michigan (111)
Minnesota (250)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1699)
New Mexico (14)
New York (1782)
North Carolina (832)
North Dakota (6)
Northern California (3526)
Ohio (185)
Oklahoma (11)
Oregon (24)
Pennsylvania (1283)
Puerto Rico (9)
Rhode Island (25)
South America (229)
South Carolina (9)
Southern California (2839)
Tennessee (41)
Texas (917)
United States (23662)
Utah (100)
Virginia (136)
Washington D.C. (39)
Washington State (595)
West Virginia (1)
Wisconsin (45)
287,738 Results for "context therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 16, 2026
January 19, 2026
·
3 min read
Press Releases
Context Therapeutics to Participate in Upcoming November 2025 Investor Conferences
October 29, 2025
·
2 min read
Press Releases
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
November 6, 2025
·
8 min read
Press Releases
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
November 10, 2025
·
5 min read
Press Releases
Oncotelic Therapeutics and Brush and Key Foundation Announce Publication in International Journal of Molecular Sciences Highlighting Context-Dependent Biomarkers in Liver and Pancreatic Cancer
December 16, 2025
·
10 min read
Press Releases
Context Therapeutics to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
·
2 min read
Press Releases
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
October 6, 2025
·
4 min read
Press Releases
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
August 7, 2025
·
6 min read
Press Releases
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 5, 2025
·
3 min read
Press Releases
Context Therapeutics Announces Chief Medical Officer Transition
May 6, 2025
·
3 min read
1 of 28,774
Next
